PNW Research & Clinical Trials Quarterly Update: Cell Therapies – Virtual

About

You’re invited to Breakthrough T1D’s Pacific Northwest Research & Clinical Trials Quarterly Update on Wednesday, December 9th, 6:30-7:30pm PT (7:30-8:30pm MT / 5:30-6:30pm AK).

This quarter’s focus is cell therapies: replacing destroyed beta cells with external insulin-producing cells and protecting them so that they can function for a very long time. Breakthrough T1D has invested more than $160 million in this work over the past 10 years. Through Project ACT (Accelerate Cell Therapies), we’re moving research, regulation, access, and adoption forward together.

Our Clinical Trial Education Volunteers, Laura Tremblay (OR), Julie Geddes (MT), Jude Restis (WA), Mark Smith (ID), and Mary Ryder (ID), will share the latest in the cell therapy pipeline.

Please reach out to [email protected] if you have any questions, or concerns.

This virtual event is free to attend, and open to everyone in the T1D community. We hope to see you on Zoom!